Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris

Accepted/In Press date: 25 July 2022

e-pub ahead of print date: 18 October 2022

Published date: 1 December 2022

Additional Information: Funding Information: This work was undertaken by the National Guideline Alliance (NGA) at the Royal College of Obstetricians and Gynaecologists (RCOG), with support from the National Institute for Health and Care Excellence (NICE) Guidelines Technical Support Unit (TSU), University of Bristol, which is funded by the NICE Centre for Guidelines. NGA has received funding from NICE to develop clinical, public health and social care guidelines. For the development of this guideline, NICE worked with the British Association of Dermatologists. The views expressed in this publication are those of the authors and not necessarily those of RCOG, NGA or NICE. The funder of the study had no further role in the study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. National Institute for Health and Care Excellence (2021) Acne Vulgaris: management. Available from: https://nice.org.uk/guidance/ng198. We thank Stephanie Arnold for conducting the systematic search of the literature on acne health state utility values and economic evaluations of acne treatments, and Shalmali Deshpande for contributing to data collection and synthesis. We also thank other members of the Guideline Committee for the NICE guideline on ‘Acne vulgaris: management’ for their contributions to this work. The members of the Committee were: Julia Cons (chair), Eugene Healy (topic advisor), Jack Higgins, Karen Joy, Sarah Mackenzie, Rebecca Penzer-Hick, Mohammed Rafiq, Jane Ravenscroft, Julia Schofield (until March 2020), Jane Wilcock and Damian Wood; co-opted members: Colin Duncan, Priya Khanna, Guy Northover, Ursula Philpot, Reena Shah and Neil Walker. Funding Information: This work was undertaken by the National Guideline Alliance (NGA) at the Royal College of Obstetricians and Gynaecologists (RCOG), with support from the National Institute for Health and Care Excellence (NICE) Guidelines Technical Support Unit (TSU), University of Bristol, which is funded by the NICE Centre for Guidelines. NGA has received funding from NICE to develop clinical, public health and social care guidelines. For the development of this guideline, NICE worked with the British Association of Dermatologists. The views expressed in this publication are those of the authors and not necessarily those of RCOG, NGA or NICE. The funder of the study had no further role in the study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. National Institute for Health and Care Excellence (2021) Acne Vulgaris: management. Available from: https://nice.org.uk/guidance/ng198 . Publisher Copyright: © 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Local EPrints ID: 472985

URI: http://eprints.soton.ac.uk/id/eprint/472985

DOI: doi:10.1111/ced.15356

ISSN: 0307-6938

PURE UUID: 7c50b5dc-40eb-4a53-ae61-138b7027cacb

Date deposited: 06 Jan 2023 17:36

Last modified: 16 Mar 2024 23:29